Replies to post #322599 on Elite Pharmaceuticals Inc (ELTP)

[NASDAQ2020]

The Monster is Coming Dec 2019 !

SunGen ANDA #2 (((((( THE GAME CHANGER ))))))

Elite’s Avatar

ER CNS stimulant
Undisclosed
Filed and under review by FDA
$1.6 Billion market
Only 3 “authorized “ generics which pay royalties to the branded
Passed alcohol dumping trial
Competition are “authorized” generics so Elite will have better cost structure
PDUFA date Dec 2019
Launch gets Elite Cash Flow Positive Feb-Mar 2020
Stops further dilution
Finances all R&D
Removes going concerns
Pays for SequestOx trials
Pays for filling SunGen#5 with $1.5 Billion Market
Massive organic growth
DollarLand !


Quote Nasrat:
“The last SunGen that was filed in May was an extended-release CNS stimulant that we co-developed with our partner SunGen. The branded and generic sales of this product are approximately $1.6 BILLION and there are currently just FOUR meanufacturers which includes the branded and its authorized generics.“

“Game Changer”

ELTP

[rrr2003]

More misinformation:

so he doesnt have 22 million shares, thanks

Actually Nasrat has 22,445,864 common shares in addition to the J series as confirmed on:

Page 4:

https://ih.advfn.com/stock-market/USOTC/elite-pharmaceuticals-inc-qb-ELTP/stock-news/80903326/proxy-statement-definitive-def-14a

. . .and 22,445,864 common shares in addition to the J series as confirmed in the current audited 10K:
Page:77

https://s3.amazonaws.com/sec.irpass.cc/2258/0001213900-19-011224.pdf